YU28800A - Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije - Google Patents

Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije

Info

Publication number
YU28800A
YU28800A YU28800A YU28800A YU28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A
Authority
YU
Yugoslavia
Prior art keywords
hyperglycaemia
medicament
manufacture
treatment
insulin sensitisers
Prior art date
Application number
YU28800A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beechem P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechem P.L.C. filed Critical Smithkline Beechem P.L.C.
Publication of YU28800A publication Critical patent/YU28800A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU28800A 1997-10-13 1998-10-12 Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije YU28800A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
YU28800A true YU28800A (sh) 2003-02-28

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28800A YU28800A (sh) 1997-10-13 1998-10-12 Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije

Country Status (24)

Country Link
EP (1) EP1023056A1 (xx)
JP (1) JP2001519382A (xx)
KR (1) KR20010024481A (xx)
CN (1) CN1281359A (xx)
AP (1) AP2000001787A0 (xx)
AU (1) AU9547098A (xx)
BG (1) BG104404A (xx)
BR (1) BR9815219A (xx)
CA (1) CA2306086A1 (xx)
CZ (1) CZ20001297A3 (xx)
EA (1) EA002659B1 (xx)
GB (1) GB9721693D0 (xx)
HR (1) HRP20000255A2 (xx)
HU (1) HUP0003922A3 (xx)
ID (1) ID24521A (xx)
IL (1) IL135513A0 (xx)
NO (1) NO20001898L (xx)
NZ (1) NZ503862A (xx)
OA (1) OA11683A (xx)
PL (1) PL339813A1 (xx)
SK (1) SK5312000A3 (xx)
TR (1) TR200000958T2 (xx)
WO (1) WO1999018943A1 (xx)
YU (1) YU28800A (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
HUP0003922A3 (en) 2001-12-28
AU9547098A (en) 1999-05-03
SK5312000A3 (en) 2000-09-12
CA2306086A1 (en) 1999-04-22
NO20001898D0 (no) 2000-04-12
BG104404A (bg) 2000-12-29
EA200000419A1 (ru) 2000-10-30
OA11683A (en) 2005-01-12
EA002659B1 (ru) 2002-08-29
CN1281359A (zh) 2001-01-24
CZ20001297A3 (cs) 2001-08-15
AP2000001787A0 (en) 2000-06-30
KR20010024481A (ko) 2001-03-26
NZ503862A (en) 2003-01-31
NO20001898L (no) 2000-06-09
EP1023056A1 (en) 2000-08-02
JP2001519382A (ja) 2001-10-23
ID24521A (id) 2000-07-20
PL339813A1 (en) 2001-01-02
GB9721693D0 (en) 1997-12-10
HRP20000255A2 (en) 2001-02-28
TR200000958T2 (tr) 2000-08-21
WO1999018943A1 (en) 1999-04-22
BR9815219A (pt) 2001-01-02
HUP0003922A2 (hu) 2001-10-28
IL135513A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
MY121517A (en) Anticonvulsant derivatives useful in reducing blood glucose levels
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
EP1572127A4 (en) TREATMENT OF FOODSTUFFS TO ENZYMES AGAINST GLUTEN ENTEROPATHY
EP1537861A3 (en) Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation
CA2294247A1 (en) Antioxidant enhancement of therapy for hyperproliferative conditions
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
EA200000814A1 (ru) Фармацевтическая композиция топирамата
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
AP9801174A0 (en) Cyclic sulfone derivatives.
WO2003096979A3 (en) Drug therapy for celiac sprue
EP0696456A3 (de) Kombination von Nekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Therapie von Tumoren und entzündlichen Erkrankungen
EP1604674A3 (en) Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
CA2253130A1 (en) A medicament for treating obesity and improving lipid metabolism
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
AU4133400A (en) Cystic fibrosis medicaments
PL323145A1 (en) Transcutaneous therapeutic system (tts) for administering testosterone
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
YU28800A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije